Category : Search result: neonatal medicine


Neonatology Pioneer Andy Whitelaw Dies Aged 79

Professor Andy Whitelaw, whose groundbreaking 'therapeutic cooling' and brain clot treatments saved countless premature babies, has died. Read about his life and legacy.

Methylene Blue: The Dangerous Wellness Trend

Wellness influencers are drinking methylene blue dye despite serious health risks. Learn why this textile dye is causing concern among medical experts and poison centres.

Pioneering trial uses old drugs to fight newborn sepsis

A groundbreaking trial in Kenya is testing repurposed antibiotics to treat neonatal sepsis, a deadly infection killing 800,000 newborns annually. Discover how this research could transform global treatment guidelines.

Mothers and Babies Heal Together from Addiction

A revolutionary approach to neonatal abstinence syndrome treats mothers and infants together, achieving 95% recovery rates while challenging traditional foster care outcomes.

UK Plan: Microchips to Replace Lab Rats in Testing

The UK government accelerates its plan to replace animal testing with advanced alternatives like 'organs-on-chips' and 3D bioprinting. Discover the timeline and the science behind this ethical shift.

PEMF Therapy Mats: Health Benefits Examined

Explore the science behind PEMF therapy mats. Experts weigh in on their potential for pain relief versus evidence-based treatments for chronic conditions in the UK.

NHS faces generic-only drug future warns AstraZeneca

The CEO of pharmaceutical giant AstraZeneca warns that UK patients may be limited to generic medicines unless the NHS increases what it pays for innovative new treatments, raising concerns about healthcare quality and medical research funding.

Art as Medicine: How Culture Heals Body and Mind

Groundbreaking research reveals how museums, galleries and cultural experiences are being prescribed by doctors to treat everything from chronic pain to mental health conditions, transforming healthcare in Britain.

UK Pharma Crisis: Patients Face Treatment Delays

A critical pricing dispute between the UK government and pharmaceutical companies threatens patient access to vital medicines, with industry leaders warning of treatment delays and reduced NHS access to new drugs.

Page 1 of 1